Exon 13 skipping mediated by HNRNPL facilitates truncated SLK-induced metastasis in hepatocellular carcinoma
Zhongxue Guo1, Peining Yu1, Liu Yu1
1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Genomic Medicine, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China.
Abstract:
The STE20-like serine/threonine-protein kinase (SLK), a key regulator of cellular signaling, exhibits remarkable functional heterogeneity through alternative splicing in various cancers. This study investigates the splicing regulation of SLK in hepatocellular carcinoma (HCC), revealing that exon 13 skipping generates functionally antagonistic isoforms: the long isoform (SLK-L, containing exon 13) acts as a tumor suppressor, whereas the short isoform (SLK-S, lacking exon 13) displays oncogenic properties. This splicing imbalance is particularly prominent during HCC metastasis, underscoring the critical role of SLK splicing regulation in tumor progression. Mechanistically, the RNA-binding protein Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL) functions as a "molecular scissor" that specifically recognizes introns 12 and 13 of SLK pre-mRNA to precisely promote SLK-S production. Functional assays demonstrate that SLK-S enhances HCC cell invasion and metastasis by activating the Extracellular signal-Regulated Kinase (ERK) signaling pathway, while SLK-L suppresses these effects through pathway inhibition. Notably, in vivo targeting of the HNRNPL/SLK-S/Rac family small GTPase 1 (Rac1)/ERK axis effectively inhibits HCC metastasis. These findings not only elucidate a novel RNA splicing regulatory mechanism in HCC metastasis but also provide a theoretical foundation and potential therapeutic targets for developing precision treatments based on SLK splicing modulation.
Insights
Alternative splicing of STE20-like serine/threonine-protein kinase (SLK) in liver cancer generates tumor-suppressing (SLK-L) and oncogenic (SLK-S) forms. Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL) drives SLK-S production, promoting metastasis.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Splicing
Background:
- STE20-like serine/threonine-protein kinase (SLK) is crucial for cellular signaling and exhibits functional diversity via alternative splicing in cancers.
- Aberrant splicing of SLK contributes to tumor progression, particularly in hepatocellular carcinoma (HCC).
Purpose of the Study:
- To investigate the role of SLK alternative splicing in HCC metastasis.
- To elucidate the regulatory mechanism of SLK splicing and its functional consequences in HCC.
Main Methods:
- Analysis of SLK splicing patterns in HCC tissues.
- Identification of RNA-binding proteins involved in SLK splicing using RNA immunoprecipitation and minigene assays.
- Functional studies using cell invasion and metastasis assays.
- In vivo xenograft models to evaluate therapeutic targeting.
Main Results:
- Exon 13 skipping in SLK generates antagonistic isoforms: SLK-L (tumor suppressor) and SLK-S (oncogene).
- Splicing imbalance favoring SLK-S is associated with HCC metastasis.
- Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL) promotes SLK-S formation by recognizing SLK pre-mRNA introns.
- SLK-S activates the Extracellular signal-Regulated Kinase (ERK) pathway, enhancing HCC cell invasion and metastasis.
- SLK-L inhibits these metastatic processes.
- Targeting the HNRNPL/SLK-S/Rac1/ERK pathway suppressed HCC metastasis in vivo.
Conclusions:
- A novel RNA splicing regulatory mechanism involving HNRNPL controls SLK isoform balance in HCC metastasis.
- SLK-S promotes HCC metastasis via the Rac1/ERK pathway, while SLK-L acts as a suppressor.
- Modulating SLK splicing presents a potential therapeutic strategy for HCC treatment.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
05:06A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Related Concept Videos
RNA Splicing
Non-LTR Retrotransposons
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Regulation of Nuclear Protein Sorting
Inheritance of Chromatin Structures
